Extrait

The primary objective of this study is to test the superiority of olanzapine compared with divalproex in improving overall manic symptomatology in patients with mild to moderate mania associated with bipolar I disorder, as measured by reductions on the Young Mania Rating Scale (YMRS) total score from baseline to the endpoint of Study Period II (3-week acute therapy phase).

Critère d'inclusion

• Manic or Mixed Episodes Associated with Bipolar I Disorder

Liens

• ictrp
• euctr